These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

592 related articles for article (PubMed ID: 22688643)

  • 1. Celecoxib enhances the anti-inflammatory effects of farnesylthiosalicylic acid on T cells independent of prostaglandin E(2) production.
    Mor A; Aizman E; Kloog Y
    Inflammation; 2012 Oct; 35(5):1706-14. PubMed ID: 22688643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of farnesylthiosalicylic acid on mediators release by mast cells: preferential inhibition of prostaglandin D(2) and tumor necrosis factor-α release.
    Mor A; Ben-Moshe O; Mekori YA; Kloog Y
    Inflammation; 2011 Oct; 34(5):314-8. PubMed ID: 20706780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ras inhibitor S-trans, trans-farnesylthiosalicylic acid enhances spatial memory and hippocampal long-term potentiation via up-regulation of NMDA receptor.
    Wang Y; Chen T; Yuan Z; Zhang Y; Zhang B; Zhao L; Chen L
    Neuropharmacology; 2018 Sep; 139():257-267. PubMed ID: 29578035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ras inhibition by FTS attenuates brain tumor growth in mice by direct antitumor activity and enhanced reactivity of cytotoxic lymphocytes.
    Aizman E; Mor A; Levy A; George J; Kloog Y
    Oncotarget; 2012 Feb; 3(2):144-57. PubMed ID: 22323550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of contact sensitivity by farnesylthiosalicylic acid-amide, a potential Rap1 inhibitor.
    Mor A; Haklai R; Ben-Moshe O; Mekori YA; Kloog Y
    J Invest Dermatol; 2011 Oct; 131(10):2040-8. PubMed ID: 21716322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D and S-farnesylthiosalicylic acid have a synergistic effect on hepatic stellate cells proliferation.
    Neeman R; Abramovitch S; Sharvit E; Elad-Sfadia G; Haklai R; Kloog Y; Reif S
    Dig Dis Sci; 2014 Oct; 59(10):2462-9. PubMed ID: 24942325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function.
    Veltman JD; Lambers ME; van Nimwegen M; Hendriks RW; Hoogsteden HC; Aerts JG; Hegmans JP
    BMC Cancer; 2010 Aug; 10():464. PubMed ID: 20804550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-inflammatory effects of celecoxib in rat lungs with smoke-induced emphysema.
    Roh GS; Yi CO; Cho YJ; Jeon BT; Nizamudtinova IT; Kim HJ; Kim JH; Oh YM; Huh JW; Lee JH; Hwang YS; Lee SD; Lee JD
    Am J Physiol Lung Cell Mol Physiol; 2010 Aug; 299(2):L184-91. PubMed ID: 20472710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anti-proliferative potency of celecoxib is not a class effect of coxibs.
    Schiffmann S; Maier TJ; Wobst I; Janssen A; Corban-Wilhelm H; Angioni C; Geisslinger G; Grösch S
    Biochem Pharmacol; 2008 Jul; 76(2):179-87. PubMed ID: 18547544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Ras-pathway inhibitor, S-trans-trans-farnesylthiosalicylic acid, suppresses experimental allergic encephalomyelitis.
    Karussis D; Abramsky O; Grigoriadis N; Chapman J; Mizrachi-Koll R; Niv H; Kloog Y
    J Neuroimmunol; 2001 Nov; 120(1-2):1-9. PubMed ID: 11694313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic reversion of invasive neurofibromin-deficient schwannoma by FTS: Ras inhibition reduces BMP4/Erk/Smad signaling.
    Barkan B; Kloog Y; Ehrlich M
    Mol Cancer Ther; 2011 Aug; 10(8):1317-26. PubMed ID: 21632464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of 2 celecoxib derivatives: analgesic effect and selectivity to cyclooxygenase-2/1.
    Lu ZH; Xiong XY; Zhang BL; Lin GC; Shi YX; Liu ZG; Meng JR; Zhou YM; Mei QB
    Acta Pharmacol Sin; 2005 Dec; 26(12):1505-11. PubMed ID: 16297351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New derivatives of farnesylthiosalicylic acid (salirasib) for cancer treatment: farnesylthiosalicylamide inhibits tumor growth in nude mice models.
    Goldberg L; Haklai R; Bauer V; Heiss A; Kloog Y
    J Med Chem; 2009 Jan; 52(1):197-205. PubMed ID: 19072665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor and anti-metastatic effects of cyclooxygenase-2 inhibition by celecoxib on human colorectal carcinoma xenografts in nude mouse rectum.
    Ninomiya I; Nagai N; Oyama K; Hayashi H; Tajima H; Kitagawa H; Fushida S; Fujimura T; Ohta T
    Oncol Rep; 2012 Sep; 28(3):777-84. PubMed ID: 22751903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway.
    Yasumaru M; Tsuji S; Tsujii M; Irie T; Komori M; Kimura A; Nishida T; Kakiuchi Y; Kawai N; Murata H; Horimoto M; Sasaki Y; Hayashi N; Kawano S; Hori M
    Cancer Res; 2003 Oct; 63(20):6726-34. PubMed ID: 14583467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib.
    Xie H; Gao L; Chai N; Song J; Wang J; Song Z; Chen C; Pan Y; Zhao L; Sun S; Wu K; Feitelson MA; Liu J; Fan D
    Mol Carcinog; 2009 Jan; 48(1):56-65. PubMed ID: 18506760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin synergistically potentiates the growth-inhibitory and pro-apoptotic effects of celecoxib in osteoarthritis synovial adherent cells.
    Lev-Ari S; Strier L; Kazanov D; Elkayam O; Lichtenberg D; Caspi D; Arber N
    Rheumatology (Oxford); 2006 Feb; 45(2):171-7. PubMed ID: 16249246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor effects of inhibitors of nitric oxide synthase or cyclooxygenase-2 on human KB carcinoma cells overexpressing COX-2.
    Ohtsu N; Takaoka K; Segawa E; Hashitani S; Noguchi K; Kishimoto H; Urade M
    Oncol Rep; 2010 Jul; 24(1):31-6. PubMed ID: 20514441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells.
    Lev-Ari S; Strier L; Kazanov D; Madar-Shapiro L; Dvory-Sobol H; Pinchuk I; Marian B; Lichtenberg D; Arber N
    Clin Cancer Res; 2005 Sep; 11(18):6738-44. PubMed ID: 16166455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PGE2 produced by lung cancer suppresses immune function through T-regulatory cells and can be blocked by the COX2 inhibitor Celebrex.
    Cancer Biol Ther; 2005 Aug; 4(8):v-vi. PubMed ID: 16710939
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 30.